[SCHEDULE 13G/A] LEMAITRE VASCULAR INC Amended Passive Investment Disclosure
Rhea-AI Filing Summary
LeMaitre Vascular, Inc. Schedule 13G/A shows George W. LeMaitre beneficially owns 1,465,235 shares of common stock, equal to 6.4% of the class. The filing states there were 22,847,733 shares outstanding as of March 31, 2026. The reported amount includes 6,847 shares subject to options exercisable within 60 days of March 31, 2026.
Positive
- None.
Negative
- None.
Insights
Owner disclosure confirms a meaningful individual stake and voting authority.
The filing lists 1,465,235 shares and reports sole voting and dispositive power over those shares. That ownership equals 6.4% of the outstanding common stock as of March 31, 2026.
Because this is a Schedule 13G/A disclosure, it documents ownership rather than indicating a change in control intentions; subsequent filings would show any change in voting plans.
Options close to exercise are included in the beneficial count.
The statement explicitly notes inclusion of 6,847 shares subject to options exercisable within 60 days of March 31, 2026, which is a standard aggregation rule for beneficial ownership.
Investor impact depends on future exercises or sales; the filing provides the precise counts and the as of March 31, 2026 outstanding base of 22,847,733 shares.